HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Diabetes & Endocrinology
RCT
Naltrexone-Bupropion Aids Weight Loss in Overweight Adults With Depression
A New Weight Loss Drug Helps Depression Too
A pooled analysis of 4 double-blind trials found that naltrexone-bupropion (NB-ER) led to significantly greater weight loss than placebo in …
A new weight loss drug helps people lose more weight while keeping their mood stable and safe for those with mild depression.
May 1, 2026
Cardiology
Cohort
Adding Bupropion or Varenicline to NRT After ACS Linked to Lower Mortality
Adding Prescription Meds to Nicotine Patches Lowers Heart Death Risk
This retrospective cohort study of 8,574 propensity-matched pairs found that adding bupropion or varenicline to NRT after ACS was associated…
Heart attack survivors who quit smoking with extra prescription help live longer.
medRxiv
Apr 24, 2026
Psychiatry
FDA Approval
FDA Approves Bupropion Hydrochloride Extended-Release Tablets (SR) (bupropion) for Major Depressive Disorder
FDA approves a new, longer-acting version of the antidepressant bupropion.
The FDA has approved Bupropion Hydrochloride Extended-Release Tablets (SR) for the treatment of major depressive disorder (MDD). Efficacy wa…
A new extended-release antidepressant now helps adults manage depression for up to 44 weeks following initial treatment.
FDA
Apr 2, 2026